Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The Publications note was updated to indicate that PubMed auto-filled publications may not be about the study, and the revision label was updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:01:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The funding/operating status notice was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:26.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study details page appears unchanged between versions; no new content or deletions are evident in the screenshots. The overall layout and information remain the same.
    Difference
    0.5%
    Check dated 2025-11-03T21:01:36.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:30:48.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated software version from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:04:15.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (up from v3.0.1). The 'Back to Top' link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:05:15.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.